Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GV1001 and Temozolomide in Advanced Malignant Melanoma
NCT01247623Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2005
- Primary completion
- Sep 2011
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of tertomotide in Malignant Melanoma (MM), sponsored by Oslo University Hospital. Started Jan 2005; status: completed.
02
Drugs
tertomotide
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT01247623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01247623.